Key facts
- This page summarizes Reginald Love's Form 4 filing for Strata Critical Medical, Inc. (SRTA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Aug 2026, 17:33.
Reginald Love - 10 Aug 2026 Form 4 Insider Report for Strata Critical Medical, Inc. (SRTA)
- Reporting relationship
- Director
- Issuer ticker
- SRTA
- Reported as of
- 10 Aug 2026
- Net transaction value
- -$29,273
- SEC form
- 4
- Accepted by SEC
- 13 Aug 2026, 17:33:00 UTC
- Prior SEC filing
- 03 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Melissa M. Tomkiel, as attorney-in-fact for Reginald Love
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Reginald Love filed Form 4 for Strata Critical Medical, Inc. (SRTA) on 13 Aug 2026.
Change
- Previous filing in this sequence was filed on 03 Aug 2026.
- Current net transaction value: -$29,273.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001749370
Primary reporting owner
Love Reginald
- Relationship
- Director
- Address
- C/O STRATA CRITICAL MEDICAL, INC., 666 THIRD AVENUE, 25TH FLOOR, NEW YORK
- Signature
- /s/ Melissa M. Tomkiel, as attorney-in-fact for Reginald Love
- Signature date
- 13 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SRTA
transaction
Class A common stock, $0.0001 par value per share
Sale
- Transaction value
- $29,273
- Shares
- -5,091
- Change %
- -3.4%
- Price
- $5.75
- Shares after
- 146,481
- Date
- 10 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.